Physician

Alexander Katz, M.D.

According to 2025 Medicare claims, Alexander Katz, M.D. (NPI: 1164453981) practices ophthalmology in the Port St. Lucie, FL market, with the plurality of this provider's patient population coming from St. Lucie, FL. This provider's primary affiliated billing organization is ALEXANDER KATZ, MD, PA (NPI: 1700202918; TIN: 464906158) and primary practice location at 34986-2349.

Katz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,748 traditional Medicare patients, billed 15,444 HCPCS/CPT codes, and received $1,209,470 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 3,518 prescription claims across 910 beneficiaries totaling $680,698 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 22 records totaling $765. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $620,647 to $1,209,470. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $151,492 to $680,698. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$605K$1.2M2015 Medicare payment: $620,647 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $691,237 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $844,775 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,102,123 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,202,071 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,009,665 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,083,637 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,158,403 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,134,141 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,209,470 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,2844,384$620,647
20161,5635,307$691,237
20171,9077,027$844,775
20182,4128,677$1,102,123
20192,7039,875$1,202,071
20202,3439,424$1,009,665
20212,41510,660$1,083,637
20222,60811,424$1,158,403
20232,66213,712$1,134,141
20242,74815,444$1,209,470

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$340K$681K2015 Drug cost: $151,492 (USD; Tot_Drug_Cst)2016 Drug cost: $207,243 (USD; Tot_Drug_Cst)2017 Drug cost: $271,611 (USD; Tot_Drug_Cst)2018 Drug cost: $355,274 (USD; Tot_Drug_Cst)2019 Drug cost: $415,153 (USD; Tot_Drug_Cst)2020 Drug cost: $469,487 (USD; Tot_Drug_Cst)2021 Drug cost: $541,865 (USD; Tot_Drug_Cst)2022 Drug cost: $537,572 (USD; Tot_Drug_Cst)2023 Drug cost: $525,446 (USD; Tot_Drug_Cst)2024 Drug cost: $680,698 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154491,481$151,492
20164921,833$207,243
20176072,241$271,611
20187953,209$355,274
20198113,200$415,153
20208093,386$469,487
20217512,923$541,865
20227503,180$537,572
20238223,195$525,446
20249103,518$680,698

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system2,2402,996$87
92012Established patient problem focused exam of visual system604938$62
92083Exam of visual field with extended testing575602$45
92134Imaging of retina1,2421,730$29
92133Imaging of optic nerve574582$24

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine1728,910$180,887
LumiganBimatoprost1095,947$48,878
CombiganBrimonidine Tartrate/Timolol783,684$27,687
XiidraLifitegrast241,260$27,244
CyclosporineCyclosporine803,720$26,735

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.22$765NEW WORLD MEDICAL,INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alexander Katz, M.D.?

Tedicare shows public-source Medicare data for Alexander Katz, M.D. (NPI 1164453981), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexander Katz, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alexander Katz, M.D.?

Alexander Katz, M.D. is linked to ALEXANDER KATZ, MD, PA (billing NPI 1700202918) in the available physician profile data.

Does Alexander Katz, M.D. have Open Payments data?

Alexander Katz, M.D. has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.